Assiut university
Asyut, 71111, Egypt
Completed
NCT Number: NCT04431440
Silver Nanoparticles in Multidrug Resistant Bacteria
Recently, silver nanoparticles (AgNPs) have been widely used in various applications as antimicrobial agents, anticancer, diagnostics, biomarkers, cell labels, and drug delivery systems for the treatment of various diseases. The present study investigated the bactericidal effect of AgNPs against Methecillin Resistant Staph. aureus (MRSA) and Vancomycin resistant Staph aureus (VRSA)
Completed
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Intensive care patients
Exclusion criteria
- none
Treatment and study plan
silver nanoparticles
Othereffect silver nanoparticles will be examined on multidrug resistant bacteria
Primary outcomes
-
bactericidal effect of silver nanoparticles on multidrug resistant bacteria
Time frame: 24 hours
Sponsors and collaborators
Lead sponsor
Assiut University
Other
Registry information
Official study title
Bactericidal Effect of Silver Nanoparticles on Methecillin and Vancomycin Resistant Staphylococcus. Aureus (MRSA) Isolated From Critically Ill Patients
Important dates
- Study start
- 2020
- Primary completion
- 2020
- Study completion
- 2020
- First posted
- Jun 16, 2020
- Registry last updated
- Nov 5, 2020
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.